Acute panmyelosis with myelofibrosis with EVI1 amplification
Authors:
- Beata GrygalewiczBGBeata Grygalewicz
- Renata WoronieckaRWRenata Woroniecka
- Anna PastwińskaAPAnna Pastwińska
- Jolanta RygierJRJolanta Rygier
- Paulina KrawczykPKPaulina Krawczyk
- Katarzyna BorgKBKatarzyna Borg
- Hanna Makuch-ŁasicaHMHanna Makuch-Łasica
- Elżbieta PatkowskaEPElżbieta Patkowska
- Barbara Pieńkowska-GrelaBPBarbara Pieńkowska-Grela
- 1 May 2012
- journal article
- case report
- Published by Elsevier in Cancer Genetics
- Vol. 205 (5) , 255-260
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimatedBlood, 2008
- Expression and prognostic significance of different mRNA 5′‐end variants of the oncogene EVI1 in 266 patients with de novo AML: EVI1 and MDS1/EVI1 overexpression both predict short remission durationGenes, Chromosomes and Cancer, 2008
- Translocation (3;8)(q26;q24): a recurrent chromosomal abnormality in myelodysplastic syndrome and acute myeloid leukemiaCancer Genetics and Cytogenetics, 2006
- EVI1 and hematopoietic disorders: History and perspectivesGene, 2006
- EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangementsGenes, Chromosomes and Cancer, 2005
- The role of EVI1 in normal and leukemic cellsBlood Cells, Molecules, and Diseases, 2003
- The EVI-1 gene — its role in pathogenesis of human leukemiasLeukemia Research, 2000
- The EVI1 gene in myeloid leukemiaLeukemia, 1997
- Expression of EVI1 in myelodysplastic syndromes and other hematologic malignancies without 3q26 translocationsBlood, 1994
- Three new cases of chromosome 3 rearrangement in bands q21 and q26 with abnormal thrombopoiesis bring further evidence to the existence of a 3q21q26 syndromeCancer Genetics and Cytogenetics, 1992